Quick answer : Possibly. Sleep and depression are closely connected, and emerging research suggests that sleep may also be related to antidepressant response following ketamine treatment. A 2026 systematic review found that ketamine was associated with improvements in subjective sleep quality and that baseline sleep disturbance and early sleep changes may have potential as predictors of antidepressant response. Sleep should therefore be evaluated as part of the broader treatment picture rather than treated as an unrelated symptom.
Sleep is sometimes treated as a secondary symptom of depression, but the relationship is much more complicated. Poor sleep can affect emotional regulation, concentration, memory, metabolic health, pain perception, inflammation, and the body’s stress response. At the same time, depression and anxiety can make it considerably harder to sleep.
This creates a cycle in which depression disrupts sleep and disrupted sleep may make recovery more difficult. Someone can receive appropriate psychiatric treatment during the day while continuing to experience fragmented or inadequate sleep every night.
That is why one of the important questions in a mental health evaluation should be simple: How are you actually sleeping?
Researchers are increasingly studying the relationship between ketamine, sleep, circadian rhythms, and antidepressant response. These areas are particularly interesting because sleep itself is closely connected with neuroplasticity and emotional processing.
A 2026 systematic review examined 26 studies involving 1,694 people with major depressive disorder or bipolar disorder. Ketamine treatment was associated with favorable changes in subjective sleep quality, and the researchers found preliminary evidence that baseline sleep disturbances and early changes in sleep may be associated with antidepressant response. Findings involving objective sleep and circadian measurements were less consistent.
This does not mean sleep can currently be used as a reliable test to determine who will respond to ketamine. It does suggest that sleep may be more closely connected with treatment response than we once appreciated.
Even when a treatment is working biologically, persistent sleep disruption can continue to produce symptoms that overlap with depression. Chronic sleep deprivation can contribute to fatigue, poor concentration, irritability, reduced motivation, and impaired emotional regulation.
Someone may therefore improve in certain aspects of depression while continuing to feel exhausted and cognitively impaired because an underlying sleep problem has not been addressed.
This is one reason we do not view mental health treatment as completely separate from sleep medicine, metabolic health, exercise, nutrition, and the rest of the body.
Insomnia is only one possibility. A broader sleep evaluation may consider how long someone sleeps, how frequently they wake up, whether their sleep schedule is consistent, and whether they wake feeling restored.
Symptoms such as loud snoring, witnessed pauses in breathing, morning headaches, waking up gasping, excessive daytime sleepiness, or persistent unrefreshing sleep may raise concern for obstructive sleep apnea. Restless legs, circadian rhythm disruption, alcohol use, cannabis use, medications, and excessive caffeine can also interfere with restorative sleep.
The appropriate evaluation depends on the individual rather than using the same testing for everyone.
We think it deserves attention. If ketamine is helping create an opportunity for improved neuroplasticity and emotional recovery, consistently poor sleep is not the biological environment we would ideally want around that process.
This does not mean perfect sleep is required for ketamine to work. It means sleep is one of several modifiable factors that can be evaluated when trying to build a more comprehensive treatment plan.
For some patients, improving sleep may involve behavioral changes. For others, it may require evaluating insomnia, sleep apnea, medications, alcohol use, circadian disruption, or another underlying problem.
Sleep is not separate from mental health. It is one of the systems that helps regulate mood, cognition, metabolism, stress, and brain function.
Ketamine should not be viewed as a treatment for insomnia or sleep apnea. However, emerging research suggests that sleep and ketamine response may be connected, making sleep an important part of the broader evaluation of treatment-resistant depression.
Some studies have reported improvements in subjective sleep following ketamine treatment for depression, although ketamine is not primarily a sleep medication. A 2026 systematic review found improvement in subjective sleep quality while objective sleep findings were less consistent.
Yes. Sleep disturbance can contribute to fatigue, cognitive problems, emotional dysregulation, and other symptoms that overlap with depression. Depression can also worsen sleep, creating a bidirectional relationship.
When symptoms or risk factors suggest obstructive sleep apnea, evaluation can be appropriate. Untreated sleep apnea can affect sleep quality, energy, cognition, cardiovascular health, and mood.
